Specimen Collection

Pre-transfusion testing only works if the sample was drawn correctly the first time, so a technologist has to be able to explain the laboratory's rules plainly and without jargon. Ward calls typically ask which tube to use, how much blood is enough, how far in advance the sample may be drawn for someone who has been pregnant or transfused recently, and why the tube must be labelled at the bedside rather than at the nursing station. The same explanation, in gentler terms, goes to a patient asking why a second draw is needed. Clear instruction prevents a rejected specimen and a delayed transfusion.

Requisitions arrive with errors of intent as well as errors of transcription. A test may have been ordered for the wrong patient, ordered twice within an hour, ordered on a component the patient cannot receive, or ordered for a purpose the assay cannot serve. The technologist is expected to notice the mismatch between what is being asked for and what the clinical situation supports, then contact the ordering service rather than either running the test silently or cancelling it unilaterally. The goal is a corrected order, not a stalled one, so the conversation matters as much as the observation.

Receiving is a deliberate comparison, not a glance. Surname, given name, unique health or hospital number, date of birth, collection date and time and the collector's identity are read off the requisition and read off the tube, and every field must agree. Transfusion services hold this to a stricter standard than the rest of the laboratory because there is no analytical step downstream that will catch a swapped identity. A single mismatched character in a date of birth or health number is a rejection, and the tube is never corrected at the bench by someone who was not present at the draw.

A correctly labelled specimen can still be unusable. Technologists inspect for red plasma from a traumatic draw, clots in an anticoagulated tube, gross lipaemia, underfilling, evidence of dilution from a running intravenous line, and tubes that have sat in transit at the wrong temperature. In transfusion work the stakes are specific: visible red supernatant destroys haemolysis as a reading endpoint, dilution weakens reverse grouping, and clotted cells give unreliable suspensions. Deciding whether to test, to qualify the report, or to ask for a redraw is a judgement made before any reagent is opened.

Some transfusion specimens carry legal weight — parentage studies, samples retained after a transfusion fatality, and specimens tied to an investigation of a transfusion error. These need more than good laboratory practice. Every person who holds the specimen signs for it, every transfer is timed and dated, seals are inspected and recorded on receipt, and the specimen is stored where access is restricted and logged. The technologist's obligation is to keep the documentary trail unbroken so that the result can survive challenge later, and to refuse a specimen whose custody record is incomplete rather than repair it after the fact.

Accessioning turns a physical tube into a traceable record. The technologist enters or verifies the patient's identifiers, the accession number, the date and time of collection, who drew it, which tests were requested, and the condition of the specimen on arrival. In transfusion medicine the system is also consulted at this moment, because it holds the historical ABO and D type, previously identified antibodies, and any special requirements such as irradiated or cytomegalovirus-negative components. Entry errors here propagate silently into every downstream step, so the record is checked against the tube rather than typed from memory.

Specimens rarely arrive one at a time. When several are waiting for transport, or several land on the receiving bench together, the technologist ranks them by how quickly the result changes what happens to the patient. A crossmatch for someone actively bleeding outranks a prenatal screen; a sample supporting a scheduled operation outranks one for a procedure next week. Ranking also accounts for stability — specimens with short viable windows cannot sit while lower-priority work is processed. Communicating the revised order to porters and to the requesting service is part of the same task.

Delivery priority and testing priority are separate decisions. Once specimens are in hand, the technologist sequences the work so that the fastest useful answer comes out first: an ABO and D type before an extended phenotype, an antibody screen before a full identification panel, an electronic or immediate-spin crossmatch before an antiglobulin crossmatch on additional units. During a massive haemorrhage protocol this ordering is what allows group-specific blood to replace emergency group O units as early as it is safe to do so. Rework and analyser downtime are anticipated rather than discovered.

Discrepancy detection is the habit of noticing when two pieces of information that should agree do not. Today's forward group against a historical type, the reverse group against the forward, the collection time against the time the order was generated, the collector's signature against who was actually on shift, the number of tubes received against the number recorded. Each of these can be the visible edge of a misidentified patient. The technologist stops, does not release results, and escalates — because the harm from investigating an innocent clerical slip is trivial next to the harm from a transfusion given to the wrong person.

Identification is the single control that transfusion safety rests on, and it is performed actively rather than by recognition. The patient is asked open questions and their answers are compared against the identification band and the requisition; the band is read, not assumed to be correct. Where a patient cannot respond — unconscious, intubated, an infant, or someone who does not share a language with the collector — an assigned unique identifier such as a trauma or alias band takes over, and it stays with that patient until identity is formally reconciled. Verification happens again at the moment of transfusion.

The physical collection determines whether testing can proceed. That means the right tube and additive, a fill volume within the marked range, adequate mixing without shaking, a needle gauge that will not shear cells, and a site chosen away from infusions, fistulas and affected limbs. Where only a vascular access device is available, the infusion is stopped and a discard volume drawn before the transfusion specimen. Cord collections have their own hazards, including contamination with Wharton's jelly and inadvertent sampling of maternal blood. The label goes on at the bedside, before the technologist leaves the patient.

Components are living or labile material and each has its own storage envelope: red cells refrigerated in a monitored, alarmed unit; platelets at room temperature with continuous gentle agitation; plasma and cryoprecipitate frozen solid. Transport containers must be validated to hold those conditions for the journey, and monitored so that a breach is detected rather than assumed not to have happened. A unit that has been out of controlled storage beyond the permitted window, or returned in an unvalidated container, is quarantined rather than returned to inventory. Every movement is documented so that any component can be traced in both directions.